Industry
Medical - Devices
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 12, 2024 | 8:07 pm
Portfolio Pulse from Benzinga Insights
June 20, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
June 03, 2024 | 8:20 pm
Portfolio Pulse from Benzinga Newsdesk
May 29, 2024 | 1:13 pm
Portfolio Pulse from Benzinga Newsdesk
May 20, 2024 | 1:02 pm
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 8:19 pm
Portfolio Pulse from Benzinga Insights
May 07, 2024 | 4:31 pm
Portfolio Pulse from Avi Kapoor
May 07, 2024 | 12:11 pm
Portfolio Pulse from Benzinga Insights
May 07, 2024 | 12:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.